Sustained Inflammation of Breast Tumors after Needle Biopsy.


Journal

Pathobiology : journal of immunopathology, molecular and cellular biology
ISSN: 1423-0291
Titre abrégé: Pathobiology
Pays: Switzerland
ID NLM: 9007504

Informations de publication

Date de publication:
2023
Historique:
received: 17 09 2021
accepted: 19 04 2022
medline: 17 4 2023
pubmed: 2 6 2022
entrez: 1 6 2022
Statut: ppublish

Résumé

Needle biopsy is essential for definitive diagnosis of breast malignancy. Significant histologic changes due to tissue damage have been reported in solid tumors. This study investigated the association between time from needle biopsy and inflammation in breast tumors. A total of 73 stage I-II invasive breast cancer cases diagnosed by image-guided needle biopsy who had surgery as their first definitive treatment were retrospectively analyzed. Time from biopsy to surgical excision ranged from 8 to 252 days. Histological sections of surgically resected tumors with a visible needle tract were reviewed by histologic evaluation. Data were analyzed by McNemar's test for proportional differences, and the Benjamini-Hochberg procedure was used to assess the association between immune cell prevalence and clinical variables. Characteristic histology changes, including foreign body giant-cell reaction, synovial-cell metaplasia, desmoplastic repair changes, granulation tissue, fat necrosis, and inflammation, were frequently detected adjacent to the needle tract. Spatial comparison indicated that a higher proportion of cases had neutrophils, eosinophils, and macrophages adjacent to the needle tract than tumors distant from it. The presence of inflammatory cells adjacent to the needle tract was not associated with time from biopsy or subtype. Still, plasma cells were associated with residual carrier material from biopsy markers. Macrophages and eosinophils are highly abundant and retained adjacent to the needle tract regardless of time from the biopsy.

Identifiants

pubmed: 35649384
pii: 000524668
doi: 10.1159/000524668
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

114-122

Informations de copyright

The Author(s). Published by S. Karger AG, Basel.

Auteurs

Cruz McCarty (C)

School of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Misung Yi (M)

Division of Biostatistics, Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Senna Sous (S)

School of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Macall Leslie (M)

Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Ezza Tariq (E)

Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Priya Dondapati (P)

Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Hiroyasu Kameyama (H)

Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Shreya Nuguri (S)

School of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Natalie Hills (N)

School of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Marielle Wilkerson (M)

School of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Rachel Davis (R)

Department of General Surgery, School of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Sidra Mesiya (S)

School of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Hallgeir Rui (H)

Department of Pathology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

Inna Chervoneva (I)

Division of Biostatistics, Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Roy Zhang (R)

Department of Pathology, School of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Takemi Tanaka (T)

Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Department of Pathology, School of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH